substance p, sar(9)-met(o2)(11)- has been researched along with Vomiting in 3 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 1 (33.33) | 18.2507 |
| 2000's | 2 (66.67) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Asai, H; Ishii, T; Kiuchi, S; Nagasaki, M; Okamoto, M; Saito, A; Taniguchi, H; Watanabe, Y | 1 |
| Field, MJ; Hughes, J; Kuo, BS; Naylor, RJ; Singh, L; Suman-Chauhan, N; Tuladhar, BR; Wright, DS | 1 |
| Chan, CC; Jolicoeur, P; Lachance, N; Rasori, R; Robichaud, A; Savoie, C; Stamatiou, PB | 1 |
3 other study(ies) available for substance p, sar(9)-met(o2)(11)- and Vomiting
| Article | Year |
|---|---|
Pharmacological characterization of T-2328, 2-fluoro-4'-methoxy-3'-[[[(2S,3S)-2-phenyl-3-piperidinyl]amino]methyl]-[1,1'-biphenyl]-4-carbonitrile dihydrochloride, as a brain-penetrating antagonist of tachykinin NK1 receptor.
Topics: Animals; Antiemetics; Antineoplastic Agents; Aprepitant; Binding Sites; Brain; Cell Line, Tumor; CHO Cells; Cisplatin; Cricetinae; Cricetulus; Disease Models, Animal; Dose-Response Relationship, Drug; Ferrets; Gerbillinae; Humans; Kinetics; Male; Morpholines; Motor Activity; Neurokinin-1 Receptor Antagonists; Peptide Fragments; Piperidines; Receptors, Neurokinin-1; Substance P; Transfection; Vomiting | 2008 |
The tachykinin NK1 receptor antagonist PD 154075 blocks cisplatin-induced delayed emesis in the ferret.
Topics: Animals; Antiemetics; Antineoplastic Agents; Behavior, Animal; Brain; CHO Cells; Cisplatin; Cricetinae; Dogs; Female; Ferrets; Gerbillinae; Guinea Pigs; Humans; Male; Mice; Neurokinin-1 Receptor Antagonists; Rats; Rats, Wistar; Sensitivity and Specificity; Sheep; Substance P; Swine; Time Factors; Tryptophan; Vomiting | 1997 |
Assessing the emetic potential of PDE4 inhibitors in rats.
Topics: 3',5'-Cyclic-AMP Phosphodiesterases; Adjuvants, Anesthesia; Adrenergic alpha-Agonists; Adrenergic alpha-Antagonists; Animals; Cyclic Nucleotide Phosphodiesterases, Type 1; Cyclic Nucleotide Phosphodiesterases, Type 4; Dose-Response Relationship, Drug; Male; Pentobarbital; Phosphodiesterase Inhibitors; Quinolizines; Rats; Rats, Sprague-Dawley; Receptors, Adrenergic, alpha-1; Receptors, Adrenergic, alpha-2; Receptors, Neurokinin-3; Substance P; Vomiting | 2002 |